The Essential Medicines for Children with Cancer: From Access to Action by OncoDaily

It is a pleasure to invite you to the “Essential Medicines for Children with Cancer: From Access to Action” OncoDaily Virtual Forum which will be held on 8-11AM EST, April 15, 2025.

The Forum will focus on the WHO Essential Medicines List for Children, the new applications including Blinatumomab and Temozolomide, the challenges different low- and middle-income countries (LMICs) are facing with the access to medications and the role of initiatives such as ACT4Children and the Global Platform for Access to Childhood Cancer Medicines (GPACCM).

Speakers will include:

• Guillermo Chantada – President of the International Society of Pediatric Oncology.
• Andre Ilbawi – Technical lead, Cancer Control Department of Noncommunicable Diseases, Rehabilitation and Disability (NCD) World Health Organization.
• Scott Howard – Deputy Director, Yeolyan Hematology/Oncology Center (Armenia), Global Development Officer, Hospital Sant Joan de Deu Barcelona (Spain) CEO, Resonance.
• Roberto Vasquez – Pediatric Oncologist, Division of Hematology and Oncology, Hospital Nacional de Ninos Benjamin Bloom, San Salvador.
• Gilles Vassal – Professor of Oncology, University Paris-Saclay, Head of Pediatric Research programme, Gustave Roussy Comprehensive Cancer Center, Chair of ITCC and ACCELERATE, Past-President, European Society of Paediatric Oncology.
• Manette Le Grange – Corporate Social Responsibility Project Lead, ICONIC, Servier.
• Yizhou Zhang – Professor and Director at the Department of Pediatric Oncology, Sun Yat-Sen University (SYSU) Cancer Center, Deputy Chairman of the Blood Disease Translational Research Committee and Standing Committee Member of Hematological Tumor Committee, Chinese Anti-Cancer Association.
• Anna Avagyan – Head of Karina Cancer Predisposition Clinic, Pediatric Hematologist, Oncologist, Pediatric Cancer and Blood Disorders Center of Armenia, Yeolyan Hematology and Oncology Center.

Moderators of the event are:

Gevorg Tamamyan – Chairman and Professor of the Department of Hematology and Pediatric Oncology, Yerevan State Medical University,CEO of the Immune Oncology Research Institute, President of the International Society of Pediatric Oncology (SIOP) Asia Continental Branch, President of the Pediatric Oncology East and Mediterranean (POEM) Group, Editor-in-Chief of OncoDaily, President of P53 Inc.

Shushan Hovsepyan – Director of Innovation and Development, Immune Oncology Research Institute, Adjunct Assistant Professor, Department of Hematology and Pediatric Oncology, Yerevan State Medical University, Co-Chair of the SIOP GHN Research and Innovation Working Group, Editor-in-Chief of OncoDaily Medical Journal, Senior VP of P53 Inc.

Registration Form:

Registration is now open for the Essential Medicines for Children with Cancer: From Access to Action OncoDaily Virtual Forum! Don’t miss the opportunity to join leading experts and advocates in the fight for better access to life-saving cancer medications for children.

The Agenda of The Essential Medicines for Children with Cancer: From Access to Action OncoDaily Virtual Forum:

The Agenda of the The Essential Medicines for Children with Cancer: From Access to Action OncoDaily Virtual Forum.